Protara Therapeutics, Inc.

Overview

Protara Therapeutics, Inc. is a publicly traded company listed on Nasdaq under the ticker TARA[2]. The company maintains its headquarters at 345 Park Avenue South, 3rd Floor, New York, NY, 10010[1]. Protara operates in the biological products industry, specifically in products excluding diagnostic substances[3]. The company was previously known as PROTEON THERAPEUTICS INC from 2006 to 2019, then ArTara Therapeutics, Inc. from 2019 to 2020, before adopting its current name[4][5][6]. In its most recent annual report to the SEC, Protara reported revenue of $2.9 million for the year ending December 31, 2014, and total assets of $209.5 million[7].

Business address: 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010. [1]

Protara Therapeutics lists its address as 345 Park Ave S, New York, New York, 10010. [9]

Financials

Reported revenue of $2.9 million for the year ending 2014-12-31 and total assets of $209.5 million in its most recent annual report to the SEC. [7]